Physician profile
William E Starr
NPI 1114097516
$15,934.15
in general payments reported to CMS, 2019-2025
14 companies · $240 in 2025
The $240 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,344 · 2020: $767 · 2021: $8,726 · 2022: $4,256 · 2023: $462 · 2024: $138 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $840.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries Lp | $13,580.10 | 2019-2023 | |
| Axogen | $865.41 | 2019-2020 | |
| Micromed INC | $694.75 | 2020 | |
| Endo Pharmaceuticals INC. | $226.62 | 2019-2024 | Xiaflex |
| Smith+Nephew, INC. | $164.56 | 2021-2025 | Stravix Pl, Renasys Touch |
| Endo USA, INC. | $120.41 | 2024-2025 | Xiaflex |
| Urgo Medical North America, LLC | $90.80 | 2023-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Kerecis Limited | $52.81 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Polynovo North America LLC | $38.55 | 2021-2025 | Novosorb Btm |
| Stryker Corporation | $25.67 | 2019 | |
| Acell, INC. | $22.56 | 2019 | |
| Misonix INC | $20.80 | 2019 | |
| Kci USA, INC. | $16.68 | 2020 | |
| Solventum Corporation | $14.43 | 2025 | V.A.C.Ulta, Prevena, V.A.C. Veraflo Cleanse Choice |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Starr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.